Titlebook: JIMD Reports, Volume 34; Eva Morava,Matthias Baumgartner,Verena Peters Book 2017 Society for the Study of Inborn Errors of Metabolism (SSI

opioid

書(shū)目名稱JIMD Reports, Volume 34影響因子(影響力)




書(shū)目名稱JIMD Reports, Volume 34影響因子(影響力)學(xué)科排名




書(shū)目名稱JIMD Reports, Volume 34網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱JIMD Reports, Volume 34網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱JIMD Reports, Volume 34被引頻次




書(shū)目名稱JIMD Reports, Volume 34被引頻次學(xué)科排名




書(shū)目名稱JIMD Reports, Volume 34年度引用




書(shū)目名稱JIMD Reports, Volume 34年度引用學(xué)科排名




書(shū)目名稱JIMD Reports, Volume 34讀者反饋




書(shū)目名稱JIMD Reports, Volume 34讀者反饋學(xué)科排名

LAP

玉米棒子

The Spectrum of PAH Mutations and Increase of Milder Forms of Phenylketonuria in Sweden During 1965 method has undergone a continuous development with not only improvements of the positive predictive value but also identification of milder forms of the disease. With the introduction of genetic testing the confirmation of the diagnosis has improved. The Swedish NBS is centralized to one laboratory

fiction

DMP1-CDG (CDG1e) with Significant Gastrointestinal Manifestations; Phenotype and Genotype Expansionnd developmental delay. Investigations of these patients revealed associated abnormal findings on brain imaging, elevated CK, abnormal clotting factors and mildly deranged serum transaminases. We describe the ninth case of DMP1-CDG, whose clinical presentation includes severe gastrointestinal involv

從屬

Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review,). The disease is life threatening if left untreated in neonates and the only available treatment option is a long-term galactose restricted diet. While this is lifesaving in the neonate, complications persist in treated individuals, and the cause of these, despite early initiation of treatment, and

BADGE

強(qiáng)有力

尋找

Paracentric Inversion of Chromosome 21 Leading to Disruption of the , Gene in a Family with Holocars including metabolic acidosis, ketosis, and hyperammonemia. A majority of HLCS deficiency patients respond to biotin therapy; however, some patients show only a partial or no response to biotin therapy. Here, we report a neonatal presentation of HLCS deficiency with partial response to biotin thera

Graphite

DOTE